Celebrating second expansion for viatel™ bioresorbable polymers manufacturing and R&D lab in Mullingar, Ireland
Supporting our globalize strategy to expand high-margin businesses, Ashland has completed the second expansion of its pharmaceutical injectables manufacturing and R&D lab in Mullingar, Ireland.
This cutting-edge facility represents a significant milestone for our company while expanding the footprint, capabilities and workforce to accelerate the delivery of innovative polymer chemistry and meet growing customer demand in the pharmaceutical, tissue engineering and medical device markets.
“Expansion of our facility in Ireland showcases Ashland’s commitment to continued innovation in injectables technology,” said Alessandra Faccin, senior vice president and general manager, life sciences, Ashland. “We are actively engaging with our customers to help them solve for performance attributes that reduce injection frequency and yield better therapy outcomes.”
“Ashland is accelerating the delivery of cutting-edge chemistry and responding to growing customer requirements for existing and new polymers with greater speed,” said Seán McMahon, Ph.D., global business manager, pharmaceutical injectables, Ashland. “Our Viatel™ bioresorbable polymers play a crucial role in developing improved treatment solutions for chronic diseases including long-acting release formulations, bioresorbable medical devices, and tissue engineering scaffolds,” McMahon concluded.
Ashland supplies over 70 GMP grades of lactide/glycolide/caprolactone copolymers within its growing Viatel™ portfolio and offers custom-made and ultrapure polymer production options.
Recently, Ashland hosted an event for customers and local dignitaries which included a ribbon cutting, presentations, lab tours and a celebratory dinner.
“It is excellent news that Ashland has completed their expansion project on their manufacturing and R&D lab at the National Science Park in Mullingar,” said Peter Burke, minister for enterprise trade and employment, Ireland. “This significant investment in my hometown and in the Midlands region itself demonstrates Ashland’s commitment to Ireland and further strengthens Ireland as a global leader in the life sciences sector.
“Ireland’s reputation as a leading hub for life sciences is further strengthened by Ashland’s expansion of its operations here,” said Mary Buckley, Executive Director of IDA Ireland. “Our supportive business environment, combined with access to the exceptional talent available in the Midlands, provides an attractive location for investment. I wish the Ashland team every success with this expansion.”
Learn more about viatel™ bioresorbable polymers.
read more >
